Navigation Links
UCLA scientist awarded $3 million to fund research into proteins affecting the kidney
Date:4/1/2014

UCLA Scientist Dr. Ira Kurtz has received a $3 million gift from the Donald T. Sterling Foundation to fund research on the structural properties of key proteins in the kidney that affect its function in health and disease. His ultimate aim is the discovery of new molecular approaches, which will aid in the development of drugs to treat patients with various kidney disorders.

"This gift will play a key role in accelerating the success of ongoing research projects in my lab," said Kurtz, a professor of medicine, who holds the Factor Chair in nephrology and serves as chief of the division of nephrology at UCLA. "There is currently a worldwide epidemic of kidney disease today. More than 500 million people worldwide have some form of kidney damage. Millions of people are affected and die each year, and a disproportionate number in the Unites States are African Americans, Latinos and other minorities."

A major goal of Kurtz's basic research program is to understand the fundamental biological processes affecting kidney function at the molecular level. One of the focuses of his lab is to unravel the atomic structure of various proteins in the kidney that contribute to kidney disease.

The proteins he studies reside either in the plasma membrane surrounding the cell, called membrane proteins, or are located inside the cell in the cytoplasm, called soluble proteins. He and his team utilize a range of methodologies, including x-ray crystallography, biochemical, cell and molecular biology, and genetic approaches to understand the structure and functional properties of kidney proteins.

By closely studying the structure of both membrane and soluble kidney proteins, Kurtz and his team hope to be able to design new therapeutics that target specific disease-causing proteins, while leaving other normal proteins unaffected.

"Determining the structure of these disease-causing proteins is vital for designing very specific drugs," he said. "If we are successful, we have the great benefit of being able to use much lower doses of a particular drug, which is very beneficial to patients, since side effects and unwanted symptoms are significantly reduced."

In the United States alone, more than 25 million people suffer from some degree of kidney function impairment, and more than 600,000 patients are on dialysis or have received a kidney transplant at a cost of more than $32 billion annually to taxpayers, Kurtz said.


'/>"/>

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-794-2262
University of California - Los Angeles Health Sciences
Source:Eurekalert  

Related biology news :

1. Behind the scenes of the IPCC report, with Stanford scientists
2. Scripps Florida scientists offer best practices nutrition measurement for researchers
3. Notre Dame scientists develop largest developmental proteomic data set for any animal
4. Research from CHORI scientists demonstrates first genome methylation in fruit fly
5. Harvard scientists visualize new treatments for retinal blindness
6. ASU scientist Roy Curtiss receives Lifetime Achievement Award from ASM
7. A*STAR scientists create stem cells from a drop of blood
8. Freiburg scientist is awarded the Paul Ehrlich and Ludwig Darmstaedter Prize
9. Plant biology discovery furthers scientists understanding of plant growth and development
10. Tropical grassy ecosystems under threat, scientists warn
11. Scientists herd cells in new approach to tissue engineering
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UCLA scientist awarded $3 million to fund research into proteins affecting the kidney
(Date:2/2/2016)... 2, 2016 This BCC Research report ... by reviewing the recent advances in high throughput ... the field forward. Includes forecast through 2019. ... challenges and opportunities that exist in the bioinformatic ... developers, as well as IT and bioinformatics service ...
(Date:2/2/2016)... , Feb. 2, 2016  Based on its ... & Sullivan recognizes US-based Intelligent Retinal Imaging Systems ... Sullivan Award for New Product Innovation. IRIS, a ... North America , is poised to ... growing diabetic retinopathy market. The IRIS technology presents ...
(Date:1/28/2016)... Jan. 28, 2016 Synaptics (NASDAQ: SYNA ), a ... its second quarter ended December 31, 2015. ... of fiscal 2016 increased 2 percent compared to the comparable quarter ... of fiscal 2016 was $35.0 million, or $0.93 per diluted share. ... income for the first quarter of fiscal 2016 grew 9 percent ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... 2016  Wellcentive today announced it has been ... -based community care organization (CCO) with more ... quality reporting and care management solutions and services. ... of quality managers, analysts and care managers while ... serving FamilyCare members. Oregon ...
(Date:2/11/2016)... 2016   BioInformant announces the February 2016 ... Products, Opportunities, Tools, and Technologies – Market Size, Segments, ... The first and only ... industry, BioInformant has more than a decade of historical ... by stem cell type. This powerful 175 page global ...
(Date:2/10/2016)... , Febr. 10, 2016 /PRNewswire/ - BioAmber Inc. (NYSE: ... to announce that Mitsui & Co. Ltd., its partner ... acid plant, is investing an additional CDN$25 million in ... its stake from 30% to 40%.  Mitsui will also ... acid produced in Sarnia , providing ...
(Date:2/10/2016)... -- ASAE is introducing a hybrid membership model which ... option of joining or renewing through an organizational purchasing ... size, every employee in any size association or AMC ... available member benefits.   John H. Graham, ... will allow organizations of any size and their employees ...
Breaking Biology Technology: